{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T01:01:51Z","timestamp":1769043711868,"version":"3.49.0"},"reference-count":15,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.3201\/eid3102.240777","type":"journal-article","created":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T21:00:32Z","timestamp":1737147632000},"source":"Crossref","is-referenced-by-count":5,"title":["<i>Borrelia spielmanii<\/i>\u2013Associated Neuroborreliosis in Patient Receiving Rituximab, Belgium"],"prefix":"10.3201","volume":"31","author":[{"given":"Timoth\u00e9e","family":"Carette","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louisien","family":"Lebrun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beno\u00eet","family":"Kabamba-Mukadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Marc","family":"Raymackers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Louis","family":"Bayart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid3102.240777-202501151632-R1","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1099\/ijs.0.64050-0","article-title":"Delineation of Borrelia burgdorferi sensu lato species by multilocus sequence analysis and confirmation of the delineation of Borrelia spielmanii sp. nov.","volume":"56","author":"Richter","year":"2006","journal-title":"Int J Syst Evol Microbiol"},{"key":"key-10.3201\/eid3102.240777-202501151632-R2","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.3201\/eid2911.230149","article-title":"Erythema migrans caused by Borrelia spielmanii, France.","volume":"29","author":"Del Giudice","year":"2023","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid3102.240777-202501151632-R3","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1136\/jnnp.2009.195438","article-title":"The chemokine CXCL13 in acute neuroborreliosis.","volume":"81","author":"Senel","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key-10.3201\/eid3102.240777-202501151632-R4","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1179\/acb.2010.069","article-title":"Prevalence and genetic heterogeneity of Borrelia burgdorferi sensu lato in Ixodes ticks in Belgium.","volume":"65","author":"Kesteman","year":"2010","journal-title":"Acta Clin Belg"},{"key":"key-10.3201\/eid3102.240777-202501151632-R5","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1468-1331.2009.02862.x","article-title":"EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis.","volume":"17","author":"Mygland","year":"2010","journal-title":"Eur J Neurol."},{"key":"key-10.3201\/eid3102.240777-202501151632-R6","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/cid\/cit235","article-title":"Performance of United States serologic assays in the diagnosis of Lyme borreliosis acquired in Europe.","volume":"57","author":"Branda","year":"2013","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid3102.240777-202501151632-R7","doi-asserted-by":"crossref","first-page":"e0292741","DOI":"10.1371\/journal.pone.0292741","article-title":"Possible effect of mutations on serological detection of Borrelia burgdorferi sensu stricto ospC major groups: An in-silico study.","volume":"18","author":"Mechai","year":"2023","journal-title":"PLoS One"},{"key":"key-10.3201\/eid3102.240777-202501151632-R8","doi-asserted-by":"crossref","first-page":"e00601","DOI":"10.1128\/JCM.00601-18","article-title":"Serological diagnostics of Lyme borreliosis: comparison of universal and Borrelia species-specific tests based on whole-cell and recombinant antigens.","volume":"56","author":"Kodym","year":"2018","journal-title":"J Clin Microbiol"},{"key":"key-10.3201\/eid3102.240777-202501151632-R9","doi-asserted-by":"crossref","first-page":"20707","DOI":"10.1073\/pnas.1108776109","article-title":"Characteristics of Borrelia hermsii infection in human hematopoietic stem cell-engrafted mice mirror those of human relapsing fever.","volume":"108","author":"Vuyyuru","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key-10.3201\/eid3102.240777-202501151632-R10","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s15010-007-6121-0","article-title":"Seronegative Lyme neuroborreliosis in a patient on treatment for chronic lymphatic leukemia.","volume":"35","author":"Harrer","year":"2007","journal-title":"Infection"},{"key":"key-10.3201\/eid3102.240777-202501151632-R11","doi-asserted-by":"crossref","first-page":"bcr2012007627","DOI":"10.1136\/bcr-2012-007627","article-title":"Seronegative lyme neuroborreliosis in a patient using rituximab.","volume":"2013","author":"van Dop","year":"2013","journal-title":"BMJ Case Rep"},{"key":"key-10.3201\/eid3102.240777-202501151632-R12","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.neurol.2015.06.009","article-title":"Seronegative Lyme neuroborreliosis in a patient treated by rituximab.","volume":"172","author":"Gampourou","year":"2016","journal-title":"Rev Neurol (Paris)"},{"key":"key-10.3201\/eid3102.240777-202501151632-R13","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1186\/s12879-018-3273-8","article-title":"Case report: persistently seronegative neuroborreliosis in an immunocompromised patient.","volume":"18","author":"Wagemakers","year":"2018","journal-title":"BMC Infect Dis"},{"key":"key-10.3201\/eid3102.240777-202501151632-R14","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3390\/ijms25010425","article-title":"CXCL13 in cerebrospinal fluid: clinical value in a large cross-sectional study.","volume":"25","author":"Erhart","year":"2023","journal-title":"Int J Mol Sci"},{"key":"key-10.3201\/eid3102.240777-202501151632-R15","doi-asserted-by":"crossref","first-page":"ofz292","DOI":"10.1093\/ofid\/ofz292","article-title":"Erythema migrans: course and outcome in patients treated with rituximab.","volume":"6","author":"Maraspin","year":"2019","journal-title":"Open Forum Infect Dis"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"deposited":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T21:00:37Z","timestamp":1737147637000},"score":1,"resource":{"primary":{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/31\/2\/24-0777_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"URL":"https:\/\/doi.org\/10.3201\/eid3102.240777","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2]]}}}